Company / Shares Outstanding
Kymera Therapeutics, Inc. Shares Outstanding History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
64.9M
FY2025
5-year range
44.5M / 64.9M
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
#135 of 212
Health Care
What the data says
At 64890193.00, Kymera Therapeutics, Inc.'s shares outstanding ranks #78 of 212 in the Health Care sector. Increased from 47989023.00 to 64890193.00 over the past 2 years.
Based on SEC 10-K filings.
64890193.00 in FY2025 with a 5-year CAGR of +102.0%.
Increased from 47989023.00 to 64890193.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +8.0%
- 5-Year CAGR
- +102.0%
- 10-Year CAGR
- -
Sector benchmark
#78 of 212 in Health CareTop 36% of 212This company 64.9M Sector average 306.0M
▼
-78.8% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 16.7% year-over-year.
- Ranks #135 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 64.9M | +16.7% |
| FY2024 | 55.6M | +15.8% |
| FY2023 | 48.0M | -6.9% |
| FY2022 | 51.5M | +15.9% |
| FY2021 | 44.5M | +2205.4% |
| FY2020 | 1.9M | +13.6% |
| FY2019 | 1.7M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026